Article in partnership with Reshape Biotech , a Danish company that develops advanced lab automation robots and a cloud-based AI platform to accelerate biological research and development. Most readers here will know mycelium as a capable, adaptable builder of structures. In forest soils it colonises particulate matter, threads itself into gaps, and stabilises the whole. Visibuilt ’s work takes that familiar behaviour and applies it to a long‑standing industrial material: mi

Too long to read? Go for the highlights below. The Fungi Foundation has released updated ethical guidelines specifically designed for ethnomycological research, marking the first framework dedicated exclusively to human-fungal knowledge systems The 2025 version emphasises that scientists must serve communities, incorporating more Latin American voices and highlighting cross-sector collaboration between academia, civil society, and Indigenous groups Successfully applied with

Too long to read? Go for the highlights below. Analysis of 133 patent filings between 2019-2024 shows mushroom-derived compounds targeting 14 therapeutic areas, with anticancer applications representing the largest cluster at 24 patents Ganoderma and Phellinus genera feature most prominently across filings, with Korea (43 patents), China (39), and the USA (27) leading global patenting activity Global medicinal mushroom market projected to reach $59.41 billion by 2031 at 8.2%

White Paper, Beyond Beta-Glucans, builds on years of scientific development to propose a compelling, evidence-based rethink. It’s time the industry moves beyond beta-glucan content as the default quality metric.

As fungi edge their way into mainstream science, innovation and culture, Vienna is positioning itself at the heart of this movement. The...